UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia

Journal of clinical oncology, 2020-12, Vol.38 (36), p.4349-4350

2020

Volltextzugriff (PDF)

Bringing PROMIS to practice: Brief and precise symptom screening in ambulatory cancer care

Cancer, 2015-03, Vol.121 (6), p.927-934

2015

Volltextzugriff (PDF)

Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women

American journal of obstetrics and gynecology, 2015-01, Vol.212 (1), p.65.e1-65.e5

2015

Volltextzugriff (PDF)

Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2011-03, Vol.29 (7), p.825-831

2011

Volltextzugriff (PDF)

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia

Obstetrics and gynecology (New York. 1953), 2016-09, Vol.128 (3), p.535-542

2016

Volltextzugriff (PDF)

An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275

Gynecologic oncology, 2020-08, Vol.158 (2), p.354-360

2020

Volltextzugriff (PDF)

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial

Journal of clinical oncology, 2024-07, Vol.42 (20), p.2425-2435

2024

Volltextzugriff (PDF)

Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: Factors associated with resistance to single-agent methotrexate chemotherapy

Gynecologic oncology, 2012-06, Vol.125 (3), p.572-575

2012

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Cancer, 2014-02, Vol.120 (3), p.344-351

2014

Volltextzugriff (PDF)

Fenretinide: a novel treatment for endometrial cancer

PloS one, 2014-10, Vol.9 (10), p.e110410

2014

Volltextzugriff (PDF)

Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery

Regional anesthesia and pain medicine, 2011-05, Vol.36 (3), p.271-277

2011

Volltextzugriff (PDF)

Fatal gestational trophoblastic neoplasia: An analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979–2012 compared to 1962–1978

Gynecologic oncology, 2015-08, Vol.138 (2), p.339-342

2015

Volltextzugriff (PDF)

Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors

Gynecologic oncology, 2011-05, Vol.121 (2), p.285-289

2011

Volltextzugriff (PDF)

Is Dexamethasone Associated with Recurrence of Ovarian Cancer?

Anesthesia and analgesia, 2014-06, Vol.118 (6), p.1213-1218

2014

Volltextzugriff (PDF)

Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin

PloS one, 2012-07, Vol.7 (7), p.e41593

2012

Volltextzugriff (PDF)

15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage

Gynecologic oncology, 2017-01, Vol.144 (1), p.200-207

2017

Volltextzugriff (PDF)

A comparison of 2 methods of vaginal cuff closure during robotic hysterectomy

International journal of gynecology and obstetrics, 2013-01, Vol.120 (1), p.99-101

2013

Volltextzugriff (PDF)

A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer

Gynecologic oncology, 2013-11, Vol.131 (2), p.362-367

2013

Volltextzugriff (PDF)

Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia

Journal of reproductive medicine, 2012-05, Vol.57 (5-6), p.219

2012

Volltextzugriff (PDF)

The Regulation and Function of the Forkhead Transcription Factor, Forkhead Box O1, Is Dependent on the Progesterone Receptor in Endometrial Carcinoma

Endocrinology (Philadelphia), 2008-04, Vol.149 (4), p.1942-1950

2008

Volltextzugriff (PDF)

Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancy

Cancer, 2008-08, Vol.113 (4), p.861-869

2008

Volltextzugriff (PDF)

Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53

Gynecologic oncology, 2004-06, Vol.93 (3), p.575-585

2004

Volltextzugriff (PDF)

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers

JNCI : Journal of the National Cancer Institute, 2014-10, Vol.106 (10), p.1

2014

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(86)
Science & Technology
(86)
Life Sciences & Biomedicine
(83)
Female
(82)
Oncology
(50)
Obstetrics & Gynecology
(48)
Middle Aged
(41)
Adult
(39)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Aged
(27)
Gynecology. Andrology. Obstetrics
(25)
Pregnancy
(25)
Tumors
(22)
Treatment Outcome
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Obstetrics And Gynecology
(19)
Chemotherapy
(18)
Neoplasm Staging
(18)
Retrospective Studies
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia

Bringing PROMIS to practice: Brief and precise symptom screening in ambulatory cancer care

Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women

Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia

An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial

Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: Factors associated with resistance to single-agent methotrexate chemotherapy

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Fenretinide: a novel treatment for endometrial cancer

Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery

Fatal gestational trophoblastic neoplasia: An analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979–2012 compared to 1962–1978

Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors

Is Dexamethasone Associated with Recurrence of Ovarian Cancer?

Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin

15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage

A comparison of 2 methods of vaginal cuff closure during robotic hysterectomy

A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer

Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia

The Regulation and Function of the Forkhead Transcription Factor, Forkhead Box O1, Is Dependent on the Progesterone Receptor in Endometrial Carcinoma

Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancy

Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53

Synuclein‐γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers

Suchergebnisse filtern